TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements), 2015, ("Listing Regulations")
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations") TORRENT PHARMACEUTICALS LTD. - 500420 - Board to consider Bonus Issue
In furtherance to the earlier communication dated 6th May, 2022 with respect to intimation of the date of the Board meeting scheduled to be held on May 25, 2022, Torrent Pharmaceuticals Ltd has now informed BSE that the Board of Directors in the said meeting would also consider the proposal for issuance of Bonus shares to the shareholders of the Company. TORRENT PHARMACEUTICALS LTD. - 500420 - Update on board meeting
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve In furtherance to our earlier communication dated 6th May, 2022 with respect to intimation of the date of the Board meeting scheduled to be held on 25th May, 2022, we would like to inform that the Board of Directors in the said meeting would also consider the proposal for issuance of Bonus shares to the shareholders of the Company. TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th May, 2022 at 07:00 P.M. to discuss the financial performance of the Company for the quarter and year ended 31st March, 2022. TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificates TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Outcome for Outcome Of Board Meeting
Appointment of Dr. Maurice Chagnaud as an Additional and Independent Director of the Company TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Dr. Maurice Chagnaud as an Additional and Independent Director of the Company TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 08-Feb-19, kindly find enclosed Annual Secretarial Compliance Report for the year ended on 31-Mar-22 issued by M/s. M. C. Gupta & Co., Practicing Company Secretaries, Ahmedabad. TORRENT PHARMACEUTICALS LTD. - 500420 - Board to consider FY22 results & Final Dividend on May 25, 2022
Torrent Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on May 25, 2022, inter alia, to consider and approve the Audited Financial Results of the Company for the year ended on March 31, 2022.In the above meeting, the Board would also consider the following:- Recommendation of final dividend, if any, on the equity. shares of the Company, for the year 2021-22.- Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes.If approved by the Board of Directors, the said item will be placed for Shareholders'' approval in the ensuing Annual General Meeting.